Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin InnoOrigin Biological Technology is a synthetic biology company specializing in the research, development, and manufacturing of high-value bioactive ingredients and probiotics. Utilizing a proprietary metabolic engineering platform, the company produces complex molecules such as Human Milk Oligosaccharides (HMOs), rare sugars, and functional postbiotics for the global nutrition and healthcare markets. InnoOrigin's technology focuses on replacing traditional chemical synthesis with sustainable, bio-based fermentation processes. The company's product portfolio supports infant formula, dietary supplements, and functional foods, aiming to enhance human health through advanced biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin InnoOrigin Biological Biotechnology.